Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRIM64FP (tripartite motif containing 64F, pseudogene) is a pseudogene in the TRIM protein family. There is no evidence it encodes a functional protein or serves as a therapeutic target. While functional TRIM proteins act primarily as E3 ubiquitin ligases involved in protein homeostasis and immunity, pseudogenes like TRIM64FP do not perform known biological or pharmacological roles and are not used as biomarkers or drug targets[2][5]. The "pseudogene" status indicates it represents a defunct copy of a gene and likely has no direct relevance in disease or therapy. If you require data on the functional TRIM64 protein (not the pseudogene), information is available regarding its involvement in ubiquitin ligase activity and innate immunity, but this does not apply to TRIM64FP[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif containing 64F, pseudogene (TRIM64FP).